KPV is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
KPV (Lysine-Proline-Valine tripeptide) is a Alpha-MSH fragment, NF-κB inhibitor researched for anti-inflammatory, IBD reduction, intestinal barrier repair, skin inflammation reduction, immune modulation. Common dosages range from 200-500 mcg daily administered once or twice daily. Below are the most frequently asked questions.
Frequently Asked Questions About KPV
What is KPV?
KPV (Lysine-Proline-Valine tripeptide) is a Alpha-MSH fragment, NF-κB inhibitor. C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH), naturally occurring from proteolytic cleavage. It is researched for anti-inflammatory, IBD reduction, intestinal barrier repair, skin inflammation reduction, immune modulation.
What is the recommended KPV dosage?
Common dosages range from 200-500 mcg daily, administered once or twice daily via oral (most studied), intranasal, subcutaneous. Cycles typically run 4-8 weeks.
What are the side effects of KPV?
No serious adverse events in preclinical studies. Theoretical potential for immune suppression at very high doses given NF-κB inhibition. GI upset possible with oral administration.
Is KPV legal?
Not FDA-approved. Expected to move from FDA Category 2 to Category 1 (allowing licensed compounding) based on 2026 regulatory developments.
What is the half-life of KPV?
The half-life of KPV is not published, which determines the once or twice daily dosing schedule.
How do you reconstitute KPV?
Add bacteriostatic water to the lyophilized KPV vial. Let the water run down the side — never spray on the powder. Swirl gently. Use our peptide calculator for exact amounts.
Can you stack KPV with other peptides?
Pairs synergistically with BPC-157 for comprehensive gut healing — KPV handles inflammation through NF-κB while BPC-157 promotes tissue repair through growth factor pathways.
Where can you buy KPV?
KPV is available as a research chemical from vetted suppliers with third-party COA testing.
How long does it take KPV to work?
Initial effects may be noticed within 1-2 weeks, with more significant results typically appearing by weeks 4-8 of a 4-8 weeks cycle.
What makes KPV unique?
The only α-MSH fragment with pure NF-κB inhibition independent of melanocortin receptors — oral bioavailability makes it uniquely practical for gut-targeted anti-inflammatory use.
Complete Guide
KPV : Benefits, Dosage, Side Effects & Research
Related Reading
Calculate Your KPV Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for KPV.
Open Calculator →Research-Grade Sourcing
If you're going to research KPV, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is KPV?
KPV (Lysine-Proline-Valine tripeptide) is a Alpha-MSH fragment, NF-κB inhibitor. C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH), naturally occurring from proteolytic cleavage. It is researched for anti-inflammatory, IBD reduction, intestinal barrier repair, skin inflammation reduction, immune modulation.
What is the recommended KPV dosage?
Common dosages: 200-500 mcg daily administered once or twice daily via oral (most studied), intranasal, subcutaneous. Cycle length: 4-8 weeks. Half-life: not published. Use our peptide calculator for exact reconstitution math.
What are the side effects of KPV?
No serious adverse events in preclinical studies. Theoretical potential for immune suppression at very high doses given NF-κB inhibition. GI upset possible with oral administration.
Is KPV safe?
KPV has shown a preliminary safety profile in research. Not FDA-approved. Expected to move from FDA Category 2 to Category 1 (allowing licensed compounding) based on 2026 regulatory developments. All research should follow appropriate safety protocols.